SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+8.99%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$765M
AUM Growth
+$765M
(+22%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
13.54%
Top 10 Holdings %
Top 10 Hldgs %
42.01%
Holding
140
New
30
Increased
44
Reduced
18
Closed
26
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$44.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
$33.5M |
| 3 |
Viatris
VTRS
|
$17.2M |
| 4 |
argenx
ARGX
|
$10.3M |
| 5 |
PTC Therapeutics
PTCT
|
$9.87M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$21.4M |
| 2 |
Amgen
AMGN
|
$18.5M |
| 3 |
Biogen
BIIB
|
$14.5M |
| 4 |
Pfizer
PFE
|
$14.1M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$13.6M |
Sector Composition
| 1 | Healthcare | 85.91% |
| 2 | Technology | 5.46% |
| 3 | Industrials | 2.69% |
| 4 | Financials | 1.45% |
| 5 | Materials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSCT
51
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $4.7M | 0.54% | 124,463 +48,063 | +63% | +$1.81M |
|
52
Kezar Life Sciences
KZR
$28.9M
| $4.54M | 0.52% | 212,000 -15,900 | -7% | -$340K |
|
|
OBSV
53
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $4.39M | 0.5% | 243,669 | – | – |
|
54
Abeona Therapeutics
ABEO
$350M
| $4.31M | 0.5% | 336,939 +113,767 | +51% | +$1.46M |
|
55
CytomX Therapeutics
CTMX
$336M
| $4.31M | 0.5% | 233,151 +150,009 | +180% | +$2.77M |
|
56
Teva Pharmaceuticals
TEVA
$21.1B
| $4.31M | 0.49% | +200,000 | New | +$4.31M |
|
|
DCPH
57
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.26M | 0.49% | 110,033 +17,002 | +18% | +$658K |
|
|
EPZM
58
DELISTED
Epizyme, Inc
EPZM
| $4.24M | 0.49% | 399,502 +92,348 | +30% | +$979K |
|
59
Evoke Pharma
EVOK
$8.49M
| $4.21M | 0.48% | 1,410,946 | – | – |
|
60
Sutro Biopharma
STRO
$72.7M
| $4.13M | 0.47% | +275,000 | New | +$4.13M |
|
61
Arvinas
ARVN
$568M
| $4.05M | 0.46% | +240,000 | New | +$4.05M |
|
|
NEOS
62
DELISTED
Neos Therapeutics, Inc
NEOS
| $4.03M | 0.46% | 831,697 +479,555 | +136% | +$2.33M |
|
63
AC Immune
ACIU
$205M
| $4.03M | 0.46% | +503,563 | New | +$4.03M |
|
64
Snap-on
SNA
$17B
| $3.98M | 0.46% | 21,666 +20,300 | +1,486% | +$3.73M |
|
|
ACGN
65
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $3.97M | 0.46% | +445,558 | New | +$3.97M |
|
66
Alphabet (Google) Class A
GOOGL
$2.57T
| $3.95M | 0.45% | 3,269 | – | – |
|
|
PTLA
67
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.92M | 0.45% | 147,000 +27,000 | +23% | +$719K |
|
68
Apellis Pharmaceuticals
APLS
$3.48B
| $3.78M | 0.43% | 212,470 +101,667 | +92% | +$1.81M |
|
69
O'Reilly Automotive
ORLY
$88B
| $3.77M | 0.43% | 10,844 | – | – |
|
70
Assembly Biosciences
ASMB
$190M
| $3.73M | 0.43% | +100,431 | New | +$3.73M |
|
|
MLNX
71
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $3.68M | 0.42% | 50,093 -35,861 | -42% | -$2.63M |
|
|
CBIO
72
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $3.62M | 0.42% | 251,013 +11,080 | +5% | +$160K |
|
|
73
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.5M | 0.4% | 40,000 -155,232 | -80% | -$13.6M |
|
|
WHWK
74
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $3.5M | 0.4% | 1,131,819 +28,265 | +3% | +$87.3K |
|
|
ALNA
75
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $3.17M | 0.36% | 295,199 +27,850 | +10% | +$299K |
|